Navigation Links
K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court
Date:8/10/2012

ST. LOUIS, Aug. 10, 2012 /PRNewswire/ -- K-V Pharmaceutical Company ("K-V" or "the Company") announced that the U.S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, today approved on an interim basis the Company's request for the use of cash collateral that was made as part of the Company's voluntary reorganization cases filed under chapter 11 of the U. S. Bankruptcy Code.

"Together with the Court's prior approval of our First Day motions, this authorization of the use of cash collateral is another important step forward, further ensuring that K-V is able to continue operations and focus on the restructuring process," said Greg Divis, President and CEO of K-V Pharmaceutical. "Meanwhile, reaching agreement regarding this matter with our Senior Noteholders sets the stage for continued cooperation toward the development of a plan of restructuring under which K-V will be able to emerge from chapter 11 as a stable and competitive company," Divis concluded.

K-V and certain of its affiliates commenced cases to reorganize under chapter 11 of the U.S. Bankruptcy Code on August 4, 2012. The chapter 11 cases are being jointly administered under case number 12-13346. 

As a further step along the path of its restructuring, the Office of the United States Trustee will hold a meeting to form an Official Committee of Unsecured Creditors on August 13, 2013. Final hearings on the First Day motions, certain other motions as well as a final hearing on the use of cash collateral are scheduled for August 23, 2012.

Updates and additional information can be found at the Company's website www.kvph.com .  In addition, the Company's Claims Administrator, Epiq Bankruptcy Solutions, Inc., maintains a web-based resource where documents from the chapter 11 cases, including the Company's Petitions, can be found, http://dm.epiq
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
2. Avanir Pharmaceuticals Reports Fiscal 2012 Third Quarter Financial And Business Results
3. K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court
4. Savient Pharmaceuticals Reports Second Quarter 2012 Financial Results
5. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
6. UCF nanoparticle discovery opens door for pharmaceuticals
7. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
8. Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
9. Pharmaceutical, Food Companies Find Presswood Pallet Ideal for BP-Free Transit Packaging
10. Optimer Pharmaceuticals Reports Second Quarter 2012 Financial Results
11. MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 Although RNA-Sequencing is ... first transcriptome-wide analyses appearing around 2008, RNA-Sequencing has ... RNA measurement. In the last several years, assays ... work with smaller input amounts, process degraded RNA, ... samples). On the bioinformatics side, there have been ...
(Date:7/31/2014)... The Kidney Cancer Association (KCA) has established a CNN ... Cancer News. , Bill Bro, KCA CEO, says, “We’re ... an international news organization. When we began using iReport last ... month’s program highlights news of an enzyme that is lost ... study. Kidney Cancer News also presents a report on outcomes ...
(Date:7/30/2014)... PARIS , July 30, 2014 /PRNewswire/ ... and NYSE: SNY) today announced that the Companies intend ... rare pediatric disease priority review voucher in connection with ... priority review voucher entitles the holder to designate a ... 6-month review from the filing date instead of the ...
(Date:7/30/2014)... , July 30, 2014  The Chicago Bears are ... Academy of Dermatology (Academy) in an effort to raise ... Bears will host free SPOT me™ skin cancer screenings ... at Soldier Field. SPOT me™ is an educational ... the dangers and risks of skin cancer, and encourages ...
Breaking Biology Technology:The Evolution of RNA-Sequencing, Upcoming Live Webinar August 22 hosted by Xtalks 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4
... Multiporator / Electroporator 2510 , , , , , , , ... Protocol No. 4308 915.511 04/2002 , , ... , , Microorganism , ... Cell type , Bacteria, gram negative, , ...
... Multiporator / Electroporator 2510 , , , , , , , ... Protocol No. 4308 915.509 12/2001 , , , ... , Microorganism , Clostridium ... type , Bacteria, gram positive, , ...
... Multiporator , , , , , , , , ... Protocol No. 4308 915.031 12/1999 , , , , , ... , Cell line , CHO, Chinese hamster ... with , Rat-DPP IV (in bidistilled H 2 O), stable transfection, , ...
Cached Biology Technology:Escherichia coli C600 2Escherichia coli C600 3Clostridium botulinum 2CHO 2
(Date:7/31/2014)... and beige adipocytes, or fat cells, are inherently different. ... each plays its own role in metabolism. In the ... most prevalent. Its primary function is energy storage. On ... generate heat but are only found in a few ... represent a special type of brown adipocytes, appear mixed ...
(Date:7/31/2014)... have shown that marine noise can affect animal movement ... Universities of Bristol and Exeter and the cole Pratique ... that boat noise stops embryonic development and increases larval ... sea slug Stylocheilus striatus used in this ... and later feed on toxic alga but this study, ...
(Date:7/30/2014)... uses reversible epigenetic processes to regulate its genes, and ... a picture of the genome regulation taking place in ... Genome Biology and illustrates how the truffle ... genes,. The authors say this may shed light on ... Black truffles (Tuber melanosporum), also known as Prigord truffles, ...
Breaking Biology News(10 mins):Hope for the overweight 2Boat noise impacts development and survival of sea hares 2How black truffles deal with the jumpers in their genome 2
... 2013 Taking a page from Chinese herbal medicine, ... today initiated the first-in-human clinical trial for pancreatic cancer ... as "Thunder God vine." The first patient ... at Scottsdale Healthcare,s Virginia G. Piper Cancer Center Clinical ...
... NY -- In plants, the growth of organs such ... of meristems. These reservoir-like compartments hold stem cells, which ... types. At Cold Spring Harbor Laboratory ... plants to obtain insights about how plants regulate their ...
... predicted that tree species will respond to global warming ... a new study of 65 different species in 31 ... Nearly 80 percent of the species aren,t yet ... staying in place -- but speeding up their life ...
Cached Biology News:TGen and Scottsdale Healthcare launch Phase I 'Thunder God vine' trial for cancer 2TGen and Scottsdale Healthcare launch Phase I 'Thunder God vine' trial for cancer 3In odd-looking mutant, clues about how maize plants control stem cell number 2Climate change may speed up forests' life cycles 2
GOAT ANTI HUMAN FACTOR 8RELATED ANTIGEN...
ANTI CORTIS BIN GLOB...
... Johnstone and M.W. Turner ... describes step-by-step methods for ... relevant molecules, the use ... specific analytical probes and ...
Request Info...
Biology Products: